2,5-dihydroxybenzoic acid has been researched along with Cardiac Hypertrophy in 1 studies
2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Heart failure was induced in mice via chronic TAC." | 1.51 | Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure. ( Choi, SY; Jeong, MH; Kee, HJ; Kee, SJ; Kim, GR; Kim, HS; Ryu, Y; Sun, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, S | 1 |
| Kee, HJ | 1 |
| Ryu, Y | 1 |
| Choi, SY | 1 |
| Kim, GR | 1 |
| Kim, HS | 1 |
| Kee, SJ | 1 |
| Jeong, MH | 1 |
1 other study available for 2,5-dihydroxybenzoic acid and Cardiac Hypertrophy
| Article | Year |
|---|---|
Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Gentisates; Heart Failure; Male; Mice; Myoc | 2019 |